Johnson Pharmacare (532154) Q1 25/26 earnings summary

Executive summary

• Board approved unaudited financial results for the quarter ended June 30, 2025, at the meeting held on July 23, 2025.

Financial highlights

• Reported a net loss of Rs. 5.34 lakhs for the quarter ended June 30, 2025, compared to a net loss of Rs. 3.99 lakhs in the same quarter last year.

• Total income for the quarter was Rs. 0.30 lakhs, down from Rs. 0.90 lakhs in the previous quarter.

• Total expenses for the quarter were Rs. 5.34 lakhs, compared to Rs. 3.99 lakhs in the same quarter last year.

• Earnings per share (EPS) for the quarter stood at Rs. (0.00), unchanged from the previous quarter.

Key financial ratios and metrics

• Paid-up equity share capital remained at Rs. 5,500.00 lakhs.

• Other equity as of March 31, 2025, was Rs. 116.91 lakhs.